SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as traders discuss a recent market dip, with some attributing it to external factors like tariff concerns and others pointing to market manipulation and leveraged positions being liquidated. The community is debating whether this is a temporary setback or the start of a larger correction, with opinions split between those expecting a quick recovery and those bracing for further declines. Despite the volatility, the long-term outlook for Bitcoin and its role as a store of value remain central talking points.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is experiencing a significant selloff, driven by concerns around potential tariffs and broader market anxieties, leading to a massive liquidation event. The community is debating the impact of these factors and whether this is a buying opportunity or the start of a deeper correction. Some are calling for prominent figures like Tom Lee to address the situation, while others are focusing on potential buying opportunities if the price continues to decline.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as community members discuss its potential breakout and recent price action, with some speculating about new highs and comparing it to Bitcoin. The conversation highlights ZEC's potential leadership in the altcoin market and its resilience during market dips, while also questioning whether it's a pump based on fundamentals or just technicals. Some traders are noting its dominance and growing volume relative to Bitcoin.

Clown Pepe, also known as Honk, its original name pepoclown, is a depiction of Pepe the Frog wearing a rainbow wig and red clown nose.  $HONK, the meme coin with 0 taxes, draws its inspiration from Clown Pepe, also known as Honk Honk or Honkler. This whimsical character, originally named pepoclown, depicts Pepe the Frog donning a rainbow wig and a red clown nose. Honkler is often associated with corny or cringeworthy jokes and the emojis, symbolizing the phrase "Clown World." Embracing the chaotic and absurd nature of meme culture, $HONK aims to bring humor, memes and vibes to the space.

Pepoclown

HONK is trending as a potential successor to PEPE, with community members highlighting its roots in 4chan culture and its association with the "clown world" meme. Some community members draw attention to the possibility of it being the next 4Chan meme to blow up. Bullish sentiment seems to be driven by the idea of it as an undervalued opportunity within the Ethereum memecoin ecosystem.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as traders discuss a significant market dip and its potential impact, with many users sharing experiences of liquidations and missed buying opportunities. Community members are debating whether the dip was caused by market manipulation, a broader economic downturn, or a combination of factors, while others remain optimistic about long-term prospects and potential ETF developments. The conversation also includes commentary on the role of influential figures and exchanges in the recent price action.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is experiencing volatility, with community members debating potential price drops and rallies. Recent market activity, possibly influenced by broader economic factors, has triggered discussions about whether to buy the dip or brace for further declines. Some traders point to historical patterns and potential support levels, while others express concern over Dogecoin's long-term prospects.

What is Chainlink? Chainlink is the industry-standard oracle platform bringing the capital markets onchain and powering the majority of decentralized finance (DeFi). Chainlink stands to benefit the most from emerging blockchain-industry trends, such as stablecoin adoption, real-world asset tokenization, and institutional adoption of blockchain technology. Chainlink is powered by the LINK token, which is used to pay for platform services and secure the network’s proper functioning. Chainlink leverages a novel fee model where offchain and onchain revenue from enterprise adoption is converted to LINK tokens and stored in a strategic Chainlink Reserve.   Chainlink is at the forefront of financial innovation and the global tokenization trend. Traditional financial institutions and infrastructures, such as Swift, DTCC, Euroclear, J.P. Morgan, Mastercard, Central Bank of Brazil, UBS, SBI, Fidelity International, ANZ,  and many others are adopting Chainlink as fundamental infrastructure as they move toward tokenizing trillions onchain. Demand for Chainlink has already generated hundreds of millions of dollars in revenue across a variety of traditional and decentralized use cases.   Chainlink is the only all-in-one platform that fulfills the requirements of any institutional blockchain use case. The Chainlink platform enables developers and institutions to access all the critical data, interoperability, compute, compliance, privacy, and legacy-system connectivity required for advanced blockchain applications that link the onchain and offchain worlds. Chainlink solves four fundamental problems for institutions interacting with tokenized assets:  The data problem. Tokenized assets need real-world information to be usable in transactions, such as market pricing, reference data, and proof of reserves data. Chainlink is the market leader in bringing real-world data onchain securely and accurately. The liquidity problem. Financial institutions need tokenized assets that can be securely accessed and moved across blockchain networks in order to maximize liquidity. Chainlink CCIP is the only cross-chain interoperability standard that securely connects any public or private blockchain, opening up global markets for tokenized assets. The synchronization problem. Tokenized assets must remain synchronized with legacy systems once issued across multiple chains. Chainlink is the only platform that offers reliable offchain data, system connectivity, and secure cross-chain interoperability, enabling a Unified Golden Record that stays with assets anywhere. The compliance problem. Regulated institutions require compliance enforcement capabilities such as identity verification (KYC), risk screening (AML), exploit protection, and asset-specific restrictions. The Chainlink Automated Compliance Engine extends existing financial infrastructure for identity and compliance data to blockchains and tokenized assets.  Since launch, the Chainlink standard has securely enabled tens of trillions in transaction value across dozens of blockchains and published tens of billions of verified messages onchain. Chainlink actively secures the large majority of DeFi protocols across different blockchains, with near total dominance on Ethereum. As a chain-agnostic platform with thousands of users across the world’s largest financial institutions and DeFi protocols, Chainlink accelerates the adoption of blockchain ecosystems and is used by tens of thousands of developers, including protocols such as Aave, GMX, Lido, and many more. How does Chainlink work? Chainlink is a set of open standards for onchain data, cross-chain interoperability, and offchain computation. The platform is powered by decentralized oracle networks (DONs), which are composed of independent oracle node operators that come to consensus over any arbitrary input to deliver highly secure and reliable data, computation, and value to its intended destination. Chainlink node operators include traditional Web2 telecommunication providers, leading data providers, and Web3 infrastructure providers such as Deutsche Telekom, Swisscom, Vodafone, and Infura.   The Chainlink data standard, including Data Feeds and Data Streams, is used to supply DeFi with financial market data; tokenized assets with proof of reserve (PoR), net asset value (NAV), assets under management (AUM); traditional institutions with identity and compliance data; and decentralized applications (dApps) with virtually any type of data point they need to function.  The Chainlink interoperability standard, powered by the Cross-Chain Interoperability Protocol (CCIP), enables data and value to move seamlessly across any public and private blockchain, as well as facilitates communication between blockchains and traditional systems, such as banks, governments, and enterprises. CCIP secures tens of billions of dollars in asset value and has enabled the transfer of billions of dollars in cross-chain value. The Chainlink compute standard, powered by the Chainlink Runtime Environment (CRE) enables developers to easily build an application that combines any data, any blockchain, any legacy systems, and computation into a unified application. With CRE, developers can easily adapt the application to support new connections without having to rewrite the app. What is the LINK token? LINK is the native token of the Chainlink Network, used for both payments and staking. Users can pay for Chainlink services in LINK tokens or in alternative assets (e.g., gas tokens) that are automatically converted into LINK via Payment Abstraction and stored in a strategic Chainlink Reserve. The Reserve is designed to support the long-term growth and sustainability of the Chainlink Network by accumulating LINK tokens using offchain revenue from large enterprises that are adopting the Chainlink standard and from onchain service usage, which has already generated hundreds of millions in revenue. Network service providers, such as node operators and LINK Stakers, also earn rewards in LINK tokens, which can be staked to support the cryptoeconomic security of the Chainlink Network.  The Chainlink platform supports a range of billing and payment models, including usage-based payments (e.g., subscription contracts and per-call models), revenue-sharing agreements (e.g., percentage of application revenue or recaptured MEV), Chainlink Build (i.e., a program where projects allocate a portion of their token supply), and Chainlink Scale (i.e., a program where blockchain ecosystems cover Chainlink service operating costs).  Chainlink Staking adds an additional layer of cryptoeconomic security to the Chainlink Network where LINK is staked (locked up) and can be slashed (forfeited) as a penalty if service providers fail to meet predefined performance requirements. Both node operators and community stakers play a critical role in supporting the reliability and integrity of the Chainlink Network.

ChainLink

Chainlink is trending as the community discusses its performance amid recent market volatility and liquidations, with some praising its data delivery during the crash.  Debate centers on its potential for growth and whether it's undervalued compared to other cryptocurrencies, while others highlight upcoming integrations and partnerships as potential catalysts. Despite positive news, some express frustration with LINK's price action, suggesting possible manipulation or poor tokenomics.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amid community frustration over price action and comparisons to other meme coins like DOGE and new entrants. Some investors are expressing concern about the long-term potential and ecosystem, while others remain confident, anticipating a future rally. Discussions also involve broader market trends and potential investment opportunities in related cryptocurrencies.

GSR III Acquisition Corp engages in the merger, share exchange, asset acquisition, share purchase or reorganization with one or more businesses. The company was founded on May 10, 2023 and is headquartered in Austin, Texas.

Terra Innovatum Global N.V.

Terra Innovatum Global N.V. Ordinary shares

Terra Innovatum Global N.V. (NKLR) is trending following its ticker change, sparking discussions about its valuation relative to other nuclear plays like $OKLO and $SMR. The community is also watching for brokerages to fully update the ticker, with some users reporting delays in trading the new symbol or converting existing shares. Some see potential for a significant run, citing the low float and growing interest in the nuclear energy sector.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

BITI is trending as traders discuss potential downside for Bitcoin, with some noting technical indicators suggesting a possible pullback. Community members are debating optimal entry points for BITI, inverse ETF on Bitcoin, while considering factors like election outcomes and broader market trends. Sentiment ranges from those expecting a near-term crypto crash to others anticipating higher Bitcoin prices, creating active discussion around hedging strategies.

statis crypto Watchlist

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

AGIO Stock Falls as FDA Delays Decision on Pyrukynd for Thalassemia

Agios shares tank as the FDA extends the review period for Pyrukynd in thalassemia by three months, pushing the final ruling to Dec. 7, 2025.

Agios Pharmaceuticals, Inc. (AGIO) announced on Thursday that the U.S. Food and Drug Administration has extended the review period for its drug Pyrukynd, intended for the treatment of adult patients with thalassemia, by three months.Thalassemia is a rare, inherited blood disease that affects the production of the protein hemoglobin in red blood cells. By disrupting hemoglobin production, thalassemia reduces the number of circulating red blood cells and shortens their lifespan, resulting in anemia, fatigue, and severe complications.While the FDA was initially expected to decide on the company’s application for Pyrukynd in treating thalassemia by September 7, its decision is now <a target="_blank" rel="noopener noreferrer nofollow" href="https://investor.agios.com/news-releases/news-release-details/agios-provides-update-us-pdufa-goal-date-pyrukyndr-mitapivat">expected</a> by December 7. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AGIO">AGIO stock</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:585/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_04_at_10_30_42_AM_png_307a186918.webp" alt="AGIO's Sentiment Meter and Message Volume as of 10:30 a.m. ET on Sept. 4, 2025 | Source: Stocktwits" width="585" height="62"><figcaption>AGIO's Sentiment Meter and Message Volume as of 10:30 a.m. ET on Sept. 4, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user opined that these are circumstances beyond the company's control.<stembedurl>https://stocktwits.com/forprofit12/message/627455227</stembedurl>A pessimistic user, however, called for selling the company's shares.<stembedurl>https://stocktwits.com/Jadek6/message/627455837</stembedurl>In the original application, the company had described the risk of hepatocellular injury with the drug. However, the firm stated on Thursday that it has submitted a proposed Risk Evaluation and Mitigation Strategy (REMS) in response to a recent information request from the agency.The extension in date of the FDA’s decision is not the result of new or additional efficacy or safety data requested by the FDA or submitted by Agios, but a result of the new REMS submission, the company said. It further termed the REMS submission a major amendment to its original application.“We remain confident in the favorable benefit-risk profile of PYRUKYND in thalassemia,” said CEO Brian Goff. &nbsp;As per Agios, approximately 6,000 adult patients are diagnosed with thalassemia in the U.S.BofA subsequently lowered its price target on Agios Pharmaceuticals to $51 from $52 while keeping a ‘Buy’ rating on the shares. The firm noted that the extension was not the result of new data requested by the FDA or submitted by the company. BofA still views approval in thalassemia as likely given its key opinion leader checks and the strength of data from late-stage trials supporting the application. As such, Agios remains one of the firm's top picks even with the delay, it said.Pyrukynd is already approved for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. Pyruvate kinase (PK) deficiency is a rare, inherited disorder causing chronic hemolytic anemia in adults, where red blood cells break down too quickly due to a lack of the PK enzyme, resulting in low red blood cell count.AGIO stock is up by 6% this year but down by over 22% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/fda-says-no-advisory-commitee-meeting-required-for-aquestive-oral-epinephrine-film/chwd20pRdYB">FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More 

While the FDA was originally expected to decide on the company’s application for Pyrukynd in treating thalassemia by September 7, its decision is now expected by December 7. 

Equity

Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?

Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Retail chatter around Agios Pharmaceuticals spiked Tuesday after the company said that Saudi Arabia’s Food and Drug Authority (SFDA) approved Pyrukynd (mitapivat) for the treatment of adult patients with alpha- or beta-thalassemia, regardless of transfusion status.The approval was granted under the SFDA’s Breakthrough Medicines Program and is based on results from the global Energize and Energize-T Phase 3 trials.&nbsp;<a href="https://stocktwits.com/symbol/AGIO">Shares of Agios Pharmaceuticals</a> closed 3.3% higher at $36.16 on Monday, with the stock rising another 2% in after-hours trading to $36.88.Agios had partnered with NewBridge Pharmaceuticals in 2024 to support regional commercialization efforts across the Gulf Cooperation Council (GCC), including the UAE, Kuwait, Qatar, Oman, and Bahrain.However, the milestone approval came alongside new safety scrutiny in the U.S. market.&nbsp;Leerink analyst Andrew Berens noted that three newly listed deaths involving Pyrukynd appeared in the FDA’s Adverse Event Reporting System (FAERS) in July, bringing the total to four since launch.Two of the July cases were in young patients. Berens called the developments “potentially concerning” but cautioned that FAERS entries often lack key details and context.In a regulatory filing, Agios said it was aware of the report and confirmed that three of the four cases had already been submitted to the FDA through standard pharmacovigilance processes.&nbsp;Two patients involved&nbsp;were treated with Pyrukynd for pyruvate kinase deficiency under its approved U.S. indication, while one patient with sickle cell disease&nbsp;was treated through expanded access.&nbsp;The fourth case had been reported directly to the FDA, and Agios said it is currently evaluating it.The company added that, to date, the available information does not change Pyrukynd’s benefit-risk profile as represented in its U.S. prescribing information.A regulatory decision on Pyrukynd for thalassemia is due from the U.S. FDA by Sept. 7. Additional filings are under review in the UAE and European Union.On Stocktwits, retail sentiment for Agios was ‘bullish’ amid ‘extremely high’ message volume.One user acknowledged not being bullish on the stock but noted that each reported death involved patients with severe underlying conditions.&nbsp;“Two were dealing with sickle cell complications, one was 93 and already critically ill — none were stable patients simply adding Pyrukynd to an existing regimen,” the user wrote, suggesting the outcomes may not reflect typical treatment scenarios.&nbsp;<stembedurl>https://stocktwits.com/Dkll303/message/623704770</stembedurl>Another user focused on the day’s sharp intraday recovery, and said the stock had an “absolutely incredible recovery.”<stembedurl>https://stocktwits.com/yachtsandthots/message/623705222</stembedurl>Agios’ stock has risen 13.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail chatter around Agios Pharmaceuticals (AGIO) spiked Tuesday after the company said that Saudi Arabia’s Food and Drug Authority (SFDA) approved Pyrukynd. (Photo credit: Getty Images)

Agios Retail Buzz Surges On Saudi Thalassemia Nod As Retail Hails ‘Incredible Recovery’ Despite FDA Concerns

Retail investors defended Agios on Stocktwits, saying reported deaths involved critically ill patients and didn’t reflect typical use. 

Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of -10.92% and +34.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Ultragenyx (RARE) Up 9.6% Since Last Earnings Report: Can It Continue?

Vertex (VRTX) Down 0.8% Since Last Earnings Report: Can It Rebound?

Earnings Preview: Agios Pharmaceuticals

4 Analysts Have This To Say About Agios Pharmaceuticals

Latest Ratings for AGIO
 DateFirmActionFromTo Mar 2022Goldman SachsMaintainsSell Mar 2022HC Wainwright & Co.MaintainsBuy Feb 2022RBC CapitalMaintainsOutperform
 View More Analyst Ratings for...

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$40.61
Prev Close	$42.43
Open	$42.51
Dividend Yield	0.00%
50-Day Moving Average	$37.84
Beta	1.22
Avg. Volume	806,876.00
PE Ratio	3.68

52-Week High	$62.58
52-Week Low	$23.42
Market Capitalization	$2.36B
EPS (Annual)	$11.64
Price to Book	1.72
Revenue Per Employee	$74,790.98
Enterprise Value/EBITDA	N/A

AGIO
Agios Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AGIO News

AGIOAgios Pharmaceuticals Inc